C. Radulescu

1.6k citations

42 papers · 791 · h-index 16

Impact in

Pulmonary and Respiratory Medicine top 5%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Oncology
- Cancer Immunotherapy and Biomarkers

Papers in

Surgery 15
- Bladder and Urothelial Cancer Treatments 14
- Urinary and Genital Oncology Studies 2
Pulmonary and Respiratory Medicine 12
- Prostate Cancer Diagnosis and Treatment 8
- Renal cell carcinoma treatment 2
- Prostate Cancer Treatment and Research 2

Co-authors: Thierry Lebrét (26 shared papers)Mathieu Rouanne (19 shared papers)Y. Neuzillet (19 shared papers)Yves Allory (9 shared papers)Vincent Molinié (9 shared papers)Henry Botto (9 shared papers)Sylvain Loric (2 shared papers)Francis Vacherot (2 shared papers)
Journals: Journal of Clinical Oncology (5 papers)The Prostate (2 papers)British Journal of Urology (2 papers)PLoS ONE (2 papers)World Journal of Urology (2 papers)
Partner nations: France Martinique Romania

In The Last Decade

C. Radulescu

40 papers receiving 789 citations

Peers

Countries citing papers authored by C. Radulescu

Since Specialization

Citations

This map shows the geographic impact of C. Radulescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Radulescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Radulescu more than expected).

Fields of papers citing papers by C. Radulescu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Radulescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Radulescu. The network helps show where C. Radulescu may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Radulescu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Radulescu Line = papers co-authored together C. Radulescu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma Cancer Research ·Clémence Granier, Charles Dariane, Pierre Combe, Virginie Verkarre, Saı̈k Urien, Cécile Badoual, Hélène Roussel, Marion Mandavit, Patrice Ravel, Mathilde Sibony, Lucie Biard, C. Radulescu, Emeline Vinatier, Nadine Benhamouda, Michaël Peyromaure, Stéphane Oudard, Arnaud Méjean, Marc‐Olivier Timsit, Alain Gey, Éric Tartour	2016	165
2	Prostate Cancer Antigen 3 Score Accurately Predicts Tumour Volume and Might Help in Selecting Prostate Cancer Patients for Active Surveillance European Urology ·Guillaume Ploussard, Xavier Durand, Évanguelos Xylinas, Stéphane Moutereau, C. Radulescu, Aurélien Forgue, Nathalie Nicolaı̈ew, Stéphane Terry, Yves Allory, Sylvain Loric, Laurent Salomon, Francis Vacherot, Alexandre de la Taille	2010	111
3	The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy British Journal of Urology ·Xavier Durand, Évanguelos Xylinas, C. Radulescu, R. Haus-Cheymol, Stéphane Moutereau, G. Ploussard, A. Forgues, G. Robert, Francis Vacherot, Sylvain Loric, Yves Allory, A. Ruffion, Alexandre de la Taille	2012	49
4	c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression Nature Communications ·Wen Jing Sim, Prasanna Vasudevan Iyengar, Dilraj Lama, Sarah Kit Leng Lui, Hsien Chun Ng, Lior Haviv-Shapira, Eytan Domany, Dennis Kappei, Tuan Zea Tan, Azad Saei, Patrick Jaynes, Chandra Verma, Alan Prem Kumar, Mathieu Rouanne, Hong Koo Ha, C. Radulescu, Peter ten Dijke, Pieter J.A. Eichhorn, Jean Paul Thiery	2019	48
5	Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer European Radiology ·Antoine Girard, Mathieu Rouanne, Sarah Taconet, C. Radulescu, Y. Neuzillet, Astrid Girma, Aurélie Bèaufrere, Thierry Lebrét, Elise Le Stanc, Jean-François Grellier	2019	42
6	Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test British Journal of Urology ·Thierry Lebrét, G. Pignot, Marc Colombel, Laurent Guy, Xavier Rébillard, L. Savareux, Mathieu Roumigue, Sebastien Nivet, Monique Coutade Saidi, Éric Piaton, C. Radulescu	2021	33
7	Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading Prostate Cancer and Prostatic Diseases ·A. Pichon, Y. Neuzillet, Henry Botto, J-P. Raynaud, C. Radulescu, Vincent Molinié, J.M. Hervé, Thierry Lebrét	2015	29
8	Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy European Journal of Surgical Oncology ·Mathieu Rouanne, A. Girma, Y. Neuzillet, D. Vilain, C. Radulescu, N. Letang, Laurent Yonneau, J.M. Hervé, Henry Botto, Elise Le Stanc, Thierry Lebrét	2014	28
9	Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non–muscle-invasive bladder cancer with positive results on urine cytology Urologic Oncology Seminars and Original Investigations ·Y. Neuzillet, C. Méthorst, Marc A. Schneider, Thierry Lebrét, Mathieu Rouanne, C. Radulescu, Vincent Molinié, Jean‐François Dreyfus, Veronique Pelcat, Henry Botto	2014	24
10	Aggressiveness of Localized Prostate Cancer: the Key Value of Testosterone Deficiency Evaluated by Both Total and Bioavailable Testosterone: AndroCan Study Results Hormones and Cancer ·Y. Neuzillet, Jean‐Pierre Raynaud, Jean‐François Dreyfus, C. Radulescu, Mathieu Rouanne, Marc A. Schneider, Sylvie Krish, Morgan Rouprêt, Sarah Drouin, Éva Compérat, Marc Galiano, Xavier Cathelineau, Pierre Validire, Vincent Molinié, Jean Fiet, Frank Giton, Thierry Lebrét, Henry Botto	2018	23
11	Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer European Journal of Cancer ·Mathieu Rouanne, R. Betari, C. Radulescu, Aïcha Goubar, Nicolas Signolle, Y. Neuzillet, Yves Allory, Aurélien Marabelle, Julien Adam, Thierry Lebrét	2019	22
12	Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score PLoS ONE ·Marie Simon, Pierre‐Olivier Bosset, Mathieu Rouanne, Simone Benhamou, C. Radulescu, Vincent Molinié, Y. Neuzillet, Xavier Paolettí, Thierry Lebrét	2019	19
13	Positive surgical margins after radical prostatectomy: What should we care about? World Journal of Urology ·C. Pettenati, Y. Neuzillet, C. Radulescu, Jean-Marie Hervé, Vincent Molinié, Thierry Lebrét	2015	18
14	A Double Blind, Randomized, Controlled Investigation of Electrodermal Testing in the Diagnosis of Allergies The Journal of Alternative and Complementary Medicine ·Julie Krop, George Lewith, W. Gziut, C. Radulescu	1997	17
15	Gleason Score within Prostate Abnormal Areas Defined by Multiparametric Magnetic Resonance Imaging Did Not Vary According to the PIRADS Score Urologia Internationalis ·H. Slaoui, Y. Neuzillet, T. Ghoneim, Mathieu Rouanne, Abdelali Abdou, Pierre Marie Lugagne-Delpon, Antoine Scherrer, C. Radulescu, Christian Delancourt, Vincent Molinié, Thierry Lebrét	2017	17
16	A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models Nuclear Medicine and Biology ·Jules Zhang-Yin, C. Provost, Géraldine Cancel‐Tassin, Timofei Rusu, Mallaurie Penent, C. Radulescu, Éva Compérat, Olivier Cussenot, Françoise Montravers, Raphaële Renard‐Penna, Jean‐Noël Talbot, Aurélie Prignon	2020	16
17	PD-L1 testing in urothelial bladder cancer: essentials of clinical practice World Journal of Urology ·Mathieu Rouanne, C. Radulescu, Julien Adam, Yves Allory	2020	14
18	Sex steroids in serum and prostatic tissue of human cancerous prostate (STERKPROSER trial) The Prostate ·M Meunier, Y. Neuzillet, Jean‐Pierre Raynaud, C. Radulescu, T. Ghoneim, Jean Fiet, Frank Giton, Mathieu Rouanne, Jean‐François Dreyfus, Thierry Lebrét, Henry Botto	2018	12
19	Inter and intra-tumor heterogeneity of PD-L1 and MET expression in metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology ·Lisa Derosa, Gwénaël Le Teuff, Manal Khordahi, Brice Chanez, E. Lechapt Zalcman, Gwénaëlle Gravis, Sylvie Négrier, C. Radulescu, Laurence Albigès, Zahira Merabet, Bernard Escudier	2017	12
20	Tumeurs germinales du testicule : caractéristiques histopathologiques et moléculaires Bulletin du Cancer ·Morgan Tourne, C. Radulescu, Yves Allory	2019	12

About C. Radulescu

C. Radulescu is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 42 papers that have together received 791 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (14 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), Hormonal and reproductive studies (3 papers), Renal cell carcinoma treatment (2 papers), CAR-T cell therapy research (2 papers), Prostate Cancer Treatment and Research (2 papers) and Urinary and Genital Oncology Studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (306 citations), Oncology (192 citations), Cancer Research (102 citations), Surgery (211 citations) and Urology (29 citations). C. Radulescu has collaborated with scholars based in France, Martinique and Romania. Frequent co-authors include Thierry Lebrét, Mathieu Rouanne, Y. Neuzillet, Yves Allory, Vincent Molinié, Henry Botto, Sylvain Loric, Francis Vacherot, Évanguelos Xylinas and Xavier Durand. Their work appears in journals such as Journal of Clinical Oncology, The Prostate, British Journal of Urology, PLoS ONE and World Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

C. Radulescu

Impact in

Papers in i

In The Last Decade

C. Radulescu

Peers

Countries citing papers authored by C. Radulescu

Fields of papers citing papers by C. Radulescu

All Works

About C. Radulescu

Explore authors with similar magnitude of impact

Papers in